Clinical trial condition

Shock

Explore clinical trials studying Shock. Study availability and eligibility vary by location and protocol.

1,179 public trials 225 recruiting studies

Refine in advanced search Browse all conditions

Shock trial results

Completed

Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS

NCT04374149

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +16 more
Locations: Prisma Health Greenville, South Carolina, United States

View Trial Details

Completed

Evaluation of CPD MNV as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)

NCT02232750

Conditions: Infections, Inflammation, Pathologic Processes, +6 more
Locations: Wexner Medical Center at The Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19

NCT04346693

Conditions: Acute Respiratory Insufficiency, Acute Respiratory Tract Infection, Hypoxemia, +16 more
Locations: Burnasyan Federal Medical Biophysical Center FMBA of Russia Moscow, Russia

View Trial Details

Completed

Early Identification and Effective Management of Pediatric Sepsis

NCT03996720

Conditions: Infections, Inflammation, Multiple Organ Failure, +8 more
Locations: Children's Hospital of Fudan University Shanghai, Shanghai Municipality, China

Children's Hospital of Shanghai Shanghai, Shanghai Municipality, China

Shanghai Children's Medical Center Shanghai, Shanghai Municipality, China

Xinhua Hospital Affiliated to Shanghai Jiaotong University Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm

NCT04362137

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +16 more
Locations: Novartis Investigative Site Fullerton, California, United States

Novartis Investigative Site Aurora, Colorado, United States

Novartis Investigative Site Denver, Colorado, United States

Novartis Investigative Site Atlanta, Georgia, United States

View all 61 locations

View Trial Details

Completed

Adrecizumab in Cardiogenic Shock

NCT03989531

Conditions: Cardiogenic Shock, Cardiovascular Diseases, Endothelial Dysfunction, +11 more
Locations: University of Berlin, Campus Benjamin-Franklin Berlin, Germany

University Heart Center Hamburg Hamburg, Germany

University of Ulm Ulm, Germany

View Trial Details

Completed

Anisodamine Critically Ill SeptIc Shock

NCT02442440

Conditions: Infections, Inflammation, Pathologic Processes, +6 more
Locations: Huizhou first hospital Huizhou, Guangdong, China

Union Hospital, Tongji medical collegue, Huazhong university of Science and Technology Wuhan, Hubei, China

the First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China

affiliated hospital, Jiangsu University Zhenjiang, Jiangsu, China

View all 15 locations

View Trial Details

Completed

Kids Intestinal Dysfunction in Congenital Heart Disease: the Kind Heart Study

NCT02824705

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +8 more
Locations: University of Arizona Tucson, Arizona, United States

View Trial Details

Completed

Vitamin C, Thiamine and Hydrocortisone for the Treatment of Septic Shock

NCT03872011

Conditions: Infections, Inflammation, Pathologic Processes, +6 more
Locations: Northern Jiangsu Province people's hospital Yangzhou, Jiangsu, China

View Trial Details

Completed

An Algorithm Driven Sepsis Prediction Biomarker

NCT03015454

Conditions: Infections, Inflammation, Pathologic Processes, +7 more
Locations: UCSF Moffit-Long Hospital San Francisco, California, United States

View Trial Details

Shock

Shock trial results

Related conditions